Western Standard LLC’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Western Standard LLC’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-294,397	Closed	-$128K	–	38
2022 Q4	$128K	Buy	+294,397	New	+$95.6K	0.11%	25

Other funds holding SIOX

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Western Standard LLC's SIOX Position: Q1 2023 in Review

Western Standard LLC sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 294,397 shares — an estimated $128K sold.

Western Standard LLC first reported a position in SIOX in Q4 2022 and held it in 1 quarter. The position peaked at $128K in Q4 2022. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

Western Standard LLC reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Western Standard LLC sold 294,397 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $128K.
Western Standard LLC first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Western Standard LLC's Sio Gene Therapies Inc. Common Stock position peaked at $128K in Q4 2022.
4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Western Standard LLC's 13F filing for Q1 2023, filed 15 May 2023.